A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Cryptosporidiosis has emerged as a leading cause of non-viral diarrhea in children under five years of age in the developing world, yet the current standard of care to treat Cryptosporidium infections, nitazoxanide, demonstrates limited and immune-dependent efficacy. Given the lack of treatments wit...
Saved in:
Main Authors: | Melissa S Love (Author), Federico C Beasley (Author), Rajiv S Jumani (Author), Timothy M Wright (Author), Arnab K Chatterjee (Author), Christopher D Huston (Author), Peter G Schultz (Author), Case W McNamara (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2017-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model.
by: Erin Stebbins, et al.
Published: (2018) -
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023) -
Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration.
by: Robert K M Choy, et al.
Published: (2020) -
A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments.
by: Christopher D Huston, et al.
Published: (2015) -
Waterborne outbreaks of cryptosporidiosis
by: Rachel M. Chalmers
Published: (2012)